Abbott Laboratories (ABT) Price to Sales (2009 - 2026)

Abbott Laboratories has disclosed Price to Sales across 18 years of filings, most recently posting 12.47 for Q2 2026.

• In Q2 2026, Price to Sales fell 41.31% year-over-year to 12.47; the TTM figure through Jun 2026 stood at 3.37 (down 38.62% YoY), while the FY2025 annual figure was 4.91, up 5.03% from the prior year.
• Price to Sales came in at 12.47 for Q2 2026 at Abbott Laboratories, down from 16.02 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 22.28 in Q1 2025 to a low of 12.47 in Q2 2026.
• Average Price to Sales over 5 years is 18.16, with a median of 18.33 recorded in 2024.
• Year-over-year, Price to Sales grew 21.94% in 2025 and tumbled 41.31% in 2026.
• Over 5 years, Price to Sales stood at 18.91 in 2022, then slipped by 1.37% to 18.65 in 2023, then fell by 4.15% to 17.88 in 2024, then gained by 6.29% to 19.0 in 2025, then slumped by 34.37% to 12.47 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 12.47 in Q2 2026, 16.02 in Q1 2026, and 19.0 in Q4 2025.